Ignite Creation Date:
2024-05-06 @ 3:12 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04555486
Status:
COMPLETED
Last Update Posted:
2024-07-11
First Post:
2020-09-02
Brief Title:
Study to Evaluate Safety Tolerability PK and PD of DCR-PHXC in PH Type 3 Patients
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS